I-124 PRE-THERAPY DOSIMETRY FOR THE TREATMENT OF DIFFERENTIATED THYROID CANCER: A SINGLE CENTER EXPERIENCE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AMINUDIN SAID MOHAMAD; NANG LEE BOON; NORSALITA ALI

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: IRANIAN JOURNAL OF NUCLEAR MEDICINE Year:2017 | Volume:25 | Issue:2 (SERIAL NUMBER 49) Page(s): 105-109

Download Full-Text

View:

215

Download:

151

Cites:

Information Journal Paper

Title

I-124 PRE-THERAPY DOSIMETRY FOR THE TREATMENT OF DIFFERENTIATED THYROID CANCER: A SINGLE CENTER EXPERIENCE

Author(s)

AMINUDIN SAID MOHAMAD | NANG LEE BOON | NORSALITA ALI | Issue Writer Certificate

Keywords

I-124

I-131

DOSIMETRY

THYROID CANCER

Abstract

Introduction: The maximum tolerable activity (MTA) of I-131 in radioiodine therapy is an established surrogate quantity to ensure that the therapeutic activity does not produce severe damages to the bone marrow and lung. The aim of this study was to estimate the MTAs for high-risk patients using I-124 pre-therapy DOSIMETRY and to compare the results with published literature.Methods: A total of 15 THYROID CANCER patients, who received I-124 pre-therapy DOSIMETRY procedure, had underwent serial blood sampling and whole-body external measurements at approximately 1–2, 4, 24, 48, and 96 h or longer after I-124 administration. The blood sampling and whole-body external measurements were used to calculate the MTA for each individual using published DOSIMETRY procedures.Results: The estimated MTAs ranged from 14 to 34 GBq. The range of blood residence and whole-body residence times were 2.6 h and 22.4 h, respectively; the 48-h whole-body retention value ranged from 2% - 14%. An overall good MTA agreement can be found between our centre and the results of the well-established centre (Essen, Germany) that included 108 patients.Conclusion: I-124 pre-therapy DOSIMETRY provides toxicity levels similar to published values. Further prospective studies are warranted to assess the benefits of I-124 pre-therapy DOSIMETRY for the individual patient and, in particular, the patient outcome.

Cites

No record.

References

No record.

Cite

APA: Copy

AMINUDIN, SAID MOHAMAD, NANG, LEE BOON, & NORSALITA, ALI. (2017). I-124 PRE-THERAPY DOSIMETRY FOR THE TREATMENT OF DIFFERENTIATED THYROID CANCER: A SINGLE CENTER EXPERIENCE. IRANIAN JOURNAL OF NUCLEAR MEDICINE, 25(2 (SERIAL NUMBER 49)), 105-109. SID. https://sid.ir/paper/716415/en

Vancouver: Copy

AMINUDIN SAID MOHAMAD, NANG LEE BOON, NORSALITA ALI. I-124 PRE-THERAPY DOSIMETRY FOR THE TREATMENT OF DIFFERENTIATED THYROID CANCER: A SINGLE CENTER EXPERIENCE. IRANIAN JOURNAL OF NUCLEAR MEDICINE[Internet]. 2017;25(2 (SERIAL NUMBER 49)):105-109. Available from: https://sid.ir/paper/716415/en

IEEE: Copy

SAID MOHAMAD AMINUDIN, LEE BOON NANG, and ALI NORSALITA, “I-124 PRE-THERAPY DOSIMETRY FOR THE TREATMENT OF DIFFERENTIATED THYROID CANCER: A SINGLE CENTER EXPERIENCE,” IRANIAN JOURNAL OF NUCLEAR MEDICINE, vol. 25, no. 2 (SERIAL NUMBER 49), pp. 105–109, 2017, [Online]. Available: https://sid.ir/paper/716415/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops